1. Akiyoshi H, Terada T. Mast cell, myofibroblast and nerve terminal complexes in carbon tetrachloride-induced cirrhotic rat livers. J Hepatol. 1998. 29:112–119.
Article
2. Bhunchet E, Eishi Y, Wake K. Contribution of immune response to the hepatic fibrosis induced by porcine serum. Hepatology. 1996. 23:811–817.
Article
3. de Souza MM, Silva LM, Barbosa AA Jr, de Oliveira IR, Parana R, Andrade ZA. Hepatic capillariasis in rats: a new model for testing antifibrotic drugs. Braz J Med Biol Res. 2000. 33:1329–1334.
Article
4. Ferreira LA, Andrade ZA. Capillaria hepatica: a cause of septal fibrosis of the liver. Mem Inst Oswaldo Cruz. 1993. 88:441–447.
Article
5. Jeong WI, Lee CS, Park SJ, Chung JY, Jeong KS. Kinetics of macrophages, myofibroblasts and mast cells in carbon tetrachloride-induced rat liver cirrhosis. Anticancer Res. 2002. 22:869–877.
6. Laskin DL. Non parenchymal cells and hepatotoxicity. Semin Liver Dis. 1990. 10:293–304.
7. Li CY, Baek JY. Mastocytosis and fibrosis: role of cytokines. Int Arch Allergy Immunol. 2002. 127:123–126.
Article
8. Neafie RC, Connor DH, Cross JH. Binford CH, Connor DH, editors. Capillariasis (intestinal and hepatic). Pathology of Tropical and Extraordinary Diseases. 1976. Vol. 2. Washington DC: Armed Forces Institute of Pathology;481–492.
9. Oliveira RF, Andrade ZA. Worm load and septal fibrosis of the liver in Capillaria hepatica-infected rats. Mem Inst Oswaldo Cruz. 2001. 96:1001–1003.
Article
10. Ramos SG, Montenegro AP, Goissis G, Rossi MA. Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum-induced rat liver fibrosis. Pathol Int. 1994. 44:655–661.
Article
11. Santos AB, Tolentino M Jr, Andrade ZA. Pathogenesis of hepatic septal fibrosis associated with Capillaria hepatica infection of rats. Rev Soc Bras Med Trop. 2001. 34:503–506.
Article
12. Shiga A, Shirota K, Ikeda T, Nomura Y. Morphological and immunohistochemical studies on porcine serum-induced rat liver fibrosis. J Vet Med Sci. 1997. 59:159–167.
Article